This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

MediSecure data breach the focus of preliminary privacy probe, Australian regulator says

( May 21, 2024, 05:57 GMT | Official Statement) -- MLex Summary: Australian digital medical-prescription provider MediSecure has notified the country’s privacy watchdog of a data breach first announced earlier this week, in which medical details of patients and personal data of doctors was accessed by hackers. In a statement, the Office of the Australian Information Commissioner said it had started a preliminary inquiry to ensure that the Melbourne-based MediSecure had responded to the breach in accordance with the Notifiable Data Breaches provisions contained in the 1988 Privacy Act. “The initial focus for the OAIC is ensuring that affected individuals are appropriately informed, so they may take steps to protect themselves from any further risk to their personal information,” the regulator said.The full statement from the Office of the Australian Information Commissioner follows: ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections